Paclitaxel is a microtubule inhibitor indicated for the treatment of: Metastatic breast cancer, after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated.
From the U.S. FDA-approved label for Paclitaxel. Full label: DailyMed.
Paclitaxel is a microtubule inhibitor indicated for the treatment of: Metastatic breast cancer, after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated. Locally advanced or metastatic non-small cell lung cancer (NSCLC), as first-line treatment in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy. Metastatic adenocarcinoma of the pancreas as first-line treatment, in combination with gemcitabine.
From the U.S. FDA-approved label for Paclitaxel. Full label: DailyMed.
Do not substitute paclitaxel protein-bound particles for injectable suspension (albumin-bound) for other paclitaxel products. Extravasation: Closely monitor the infusion site for extravasation and infiltration. Metastatic Breast Cancer (MBC): Recommended dosage of paclitaxel protein-bound particles for injectable suspension (albumin-bound) is 260 mg/m2 intravenously over 30 minutes every 3 weeks.
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
Paclitaxel protein-bound particles for injectable suspension (albumin-bound) is contraindicated in patients with: Baseline neutrophil counts of < 1,500 cells/mm 3 A history of severe hypersensitivity reactions to paclitaxel protein-bound particles for injectable suspension (albumin-bound). Neutrophil counts of < 1,500 cells/mm 3. Severe hypersensitivity reactions to paclitaxel.
Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.
Sensory neuropathy occurs frequently and may require dose reduction or treatment interruption. Sepsis occurred in patients with or without neutropenia who received paclitaxel protein-bound particles for injectable suspension (albumin-bound) in combination with gemcitabine; interrupt paclitaxel protein-bound particles for injectable suspension (albumin-bound) and gemcitabine until sepsis resolves, and if neutropenia, until neutrophils are at least 1500 cells/mm 3, then resume treatment at reduced dose levels.
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
146 products from 53 makers in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| C-Celtax 260MG/43.3ML Injection | Paclitaxel (260MG/43.3ML) | Celon Lab | |
| Intaxel 260 260mg Tablet | Paclitaxel (260mg) | Fresenius Kabi pharmaceuticals | |
| Mitotax 100mg/ml Injection | Paclitaxel (100mg/ml) | Dr. Reddy's Laboratories. | |
| Mitotax 250mg/ml Injection | Paclitaxel (250mg/ml) | Dr. Reddy's Laboratories. | |
| Paclitax 100 100mg Injection | Paclitaxel (100mg) | Cipla Ltd. | |
| Paclitax 260 260mg Injection | Paclitaxel (260mg) | Cipla Ltd. | |
| Paclitax 30 30mg Injection | Paclitaxel (30mg) | Cipla Ltd. | |
| Pacliwel 100mg/ml Injection | Paclitaxel (100mg/ml) | Getwell Pharmaceuticals | |
| Pacliwel 260mg Injection | Paclitaxel (260mg) | Getwell Pharmaceuticals | |
| Pacliwel 30mg/ml Injection | Paclitaxel (30mg/ml) | Getwell Pharmaceuticals | |
| Petaxel 100 100mg Injection | Paclitaxel (100mg) | Biochem Pharmaceuticals Industries Limited. | |
| Petaxel 260 260mg Injection | Paclitaxel (260mg) | Biochem Pharmaceuticals Industries Limited. | |
| Petaxel 30 30gm Injection | Paclitaxel (30gm) | Biochem Pharmaceuticals Industries Limited. | |
| AB-Pacli 100mg Injection | Paclitaxel (100mg) | Adley Formulations | vial of 1 Injection |
| Abra Bound Suspension for Injection | Paclitaxel (1000mg) | Arechar Healthcare | vial of 1 Suspension for Injection |
| Abraxane 100mg Injection | Paclitaxel (100mg) | Biocon | vial of 1 Injection |
| Acopacli 100 Injection | Paclitaxel (100mg) | Accord Pharmaceuticals | vial of 16.7 ml Injection |
| Acopacli 260 Injection | Paclitaxel (260mg) | Accord Pharmaceuticals | vial of 1 Injection |
| Acopacli 30 Injection | Paclitaxel (30mg) | Accord Pharmaceuticals | vial of 5 ml Injection |
| Adpaxil 100mg Injection | Paclitaxel (100mg) | Adley Formulations | vial of 16.7 ml Injection |
| Adpaxil 260mg/43.4ml Injection | Paclitaxel (6mg/ml) | Adley Formulations | vial of 43.4 ml Injection |
| Adpaxil 300mg Injection | Paclitaxel (300mg) | Adley Formulations | vial of 1 Injection |
| Adpaxil 30mg/5ml Injection | Paclitaxel (6mg/ml) | Adley Formulations | vial of 5 ml Injection |
| Albumaps 100mg Injection | Paclitaxel (100mg) | AMPS Biotech Pvt Ltd | vial of 1 Injection |
| Altaxel 100mg Injection | Paclitaxel (100mg) | Alkem Laboratories Ltd | vial of 1 Injection |
| Altaxel 250mg Injection | Paclitaxel (250mg) | Alkem Laboratories Ltd | vial of 1 Injection |
| Altaxel 260mg Injection | Paclitaxel (260mg) | Alkem Laboratories Ltd | vial of 1 Injection |
| Altaxel 300mg Infusion | Paclitaxel (300mg) | Alkem Laboratories Ltd | bottle of 50 ml Infusion |
| Altaxel 30mg Injection | Paclitaxel (30mg) | Alkem Laboratories Ltd | vial of 1 Injection |
| Altaxel Nova 100mg Injection | Paclitaxel (100mg) | Alkem Laboratories Ltd | vial of 1 Injection |
Showing 30 of 146 catalog products. Search the full catalog in the app.
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
Protect from bright light.
Storage information from the U.S. FDA-approved label.
Paclitaxel is recorded in the NepalDoc medicine catalog for: Ovarian carcinoma, Breast cancer, Lung cancer, Kaposi's sarcoma.
For Breast cancer: Capecitabine, Epirubicin, Letrozole, Melphalan, Norethisterone, Tamoxifen.
For Lung cancer: Gemcitabine.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. NLEM listing does not guarantee that a medicine is in stock at any pharmacy.
